Aspire Ventures Precision Medicine Fund, LLC — Form D
Aspire Ventures Precision Medicine Fund, LLC of LANCASTER, PA, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2017-12-13. The offering totals $200.0M, of which $30.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2017-12-13
- Form: D
- Accession: 0001724843-17-000001
- Industry: Pooled Investment Fund
- Exemptions: 06c, 3C, 3C.1
- Total offering: $200.0M
- Amount sold: $30.0M
- Remaining: $170.0M
- Minimum investment: $1.0M
- Investors: 2
- Date of first sale: 2017-11-22
- Security types: equity, fund interests
- Revenue range: Not Applicable
- SEC file number: 021-300587
Issuer
- Name: Aspire Ventures Precision Medicine Fund, LLC
- CIK: 0001724843
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 100 NORTH QUEEN STREET, LANCASTER, PA, 17603
- Phone: 717-405-1011
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Essam Abadir | Executive Officer | Lancaster, PA |
| Medicine Manager, LLC Aspire Ventures Precision | Executive Officer | Lancaster, PA |
| Todd Bartos | Executive Officer | PACIFIC PALISADES, CA |
More